Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

M Quan, X Wang, M Gong, Q Wang, Y Li… - The Lancet Regional …, 2023 - thelancet.com
Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three …

Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing

AA El-Malah, MM Gineinah, PK Deb, AN Khayyat… - Pharmaceuticals, 2022 - mdpi.com
The introduction of selective COX-2 inhibitors (so-called 'coxibs') has demonstrated
tremendous commercial success due to their claimed lower potential of serious …

[HTML][HTML] Постковидные неврологические синдромы

ВВ Белопасов, ЕН Журавлева… - Клиническая …, 2021 - cyberleninka.ru
В статье освещены патогенез, клинические проявления поражения центральной и
периферической нервной системы, возникшие или сохраняющиеся у больных в …

Post-covid-19 neurological syndromes

VV Belopasov, EN Zhuravleva… - Journal of Clinical …, 2021 - journals.eco-vector.com
The article highlights the pathogenesis, clinical manifestations of lesions of the central and
peripheral nervous system that have arisen or persist in patients in the postcoid period …

Identification of Coronary Artery Disease using Extra Tree Classification

N Wahid, A Zaidi, G Dhiman, M Manwal… - 2023 International …, 2023 - ieeexplore.ieee.org
Caused by a shortage of oxygen-rich blood, cardiac artery disease occurs when coronary
arteries get blocked. Arterial occlusion decreases the heart's blood flow and hence its …

Mitophagy in the aging nervous system

A Rappe, TG McWilliams - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Aging is characterised by the progressive accumulation of cellular dysfunction, stress, and
inflammation. A large body of evidence implicates mitochondrial dysfunction as a cause or …

An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)

P Pagliano, C Sellitto, G Scarpati… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Remdesivir (RDV) is an inhibitor of the viral RNA-dependent RNA polymerases
that are active in some RNA viruses, including the Ebola virus and zoonotic coronaviruses …

Interferon-gamma mediated metabolic pathways in hospitalized patients during acute and reconvalescent COVID-19

M Gietl, F Burkert, S Seiwald, A Böhm… - International …, 2023 - journals.sagepub.com
Background: Fatigue, sleep disturbance, and neurological symptoms during and after
COVID-19 are common and might be associated with inflammation-induced changes in …

Development of new mental and physical health sequelae among US veterans after COVID-19

N Patel, B Dahman, JS Bajaj - Journal of clinical medicine, 2022 - mdpi.com
Background: COVID-19 sequelae among veterans need evaluation. Design: Propensity-
score-matched retrospective cohort study. Participants: A total 778,738 veterans, who were …

[HTML][HTML] Nervous system manifestations related to COVID-19 and their possible mechanisms

Z Xie, H Hui, Z Zhao, W Yu, R Wu, Y Zhu, Y Song… - Brain Research …, 2022 - Elsevier
In December 2019, the novel coronavirus disease (COVID-19) due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection broke. With the gradual …